Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy. Among RNA-based ...
News-Medical.Net on MSN
Breakthrough study reveals how rabies virus uses few proteins to hijack cells
New antivirals and vaccines could follow the discovery by Australian researchers of strategies used by viruses to control our ...
Mayo Clinic on MSN
Different types of COVID-19 vaccines: How they work
Find out how different vaccines for the coronavirus cause your body to create antibodies that fight the virus.
Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...
There are a number of considerations that can help streamline the pathway to the clinic. One of the first is which vector ...
1don MSN
Molecular dynamics simulations use atomistic force field to capture RNA folding with high accuracy
Ribonucleic acid (RNA) is one of life's most versatile molecules, with roles going far beyond being a messenger of genetic ...
Vishal Mukund Sonje, Vaccine Manufacturing Lead, CEPI, talks about the challenges that arise in the manufacturing of vaccines ...
Background: Toys in pediatric office waiting rooms may be fomites for transmission of viruses. Methods: Eighteen samples were taken from office objects on 3 occasions. Samples were tested for presence ...
Ottawa, Oct. 06, 2025 (GLOBE NEWSWIRE) -- The global viral vector gene therapy market size was valued at USD 13.14 billion in 2024 and is predicted to hit around USD 38.39 billion by 2034, rising at a ...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the best mid cap growth stocks to invest in now. Earlier on June 4, Sarepta Therapeutics announced that the US FDA has granted Platform Technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback